Sirolimus-eluting coronary stents: a review

References

• AlfonsoFPerez-VazcaynoMJHernandezRA randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trialJ Am Coll Cardiol20064721526016750678
   PubMed Web of Science ®Google Scholar
• AokiJOngARodriguez GranilloGA“Full metal jacket” (stented length >r = 64 mm) using drug-eluting stents for de novo coronary artery lesionsAm Heart J2005150994916290984
   PubMed Web of Science ®Google Scholar
• ArdissinoDCavalliniCBramucciESirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trialJAMA200429227273415585732
   PubMed Web of Science ®Google Scholar
• BavryAAKumbhaniDJHeltonTJBhattDLRisk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)Am J Cardiol20059514697215950574
   PubMedGoogle Scholar
• ChakrabortyTKWeberHPNicolaouKCDesign and synthesis of a rapamycin-based high affinity binding FKBR12 ligandChem Biol Mar1995215761
   PubMedGoogle Scholar
• ChangJYSehgalSNBansbachCCFK506 and rapamycin novel pharmacological probes of the immune responseTrends Pharmacol Sci199112218231710854
   PubMed Web of Science ®Google Scholar
• ColomboACorbettSJDrug-eluting stent thrombosis: increasingly recognized but too frequently overemphasizedJ Am Coll Cardiol200648203516814668
   PubMedGoogle Scholar
• DibraAKastratiAMehilliJPaclitaxel-eluting or sirolimuseluting stents to prevent restenosis in diabetic patientsN Engl J Med20053536637016105990
   PubMed Web of Science ®Google Scholar
• GalloRPadureanAJayaramanTInhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycleCirculation19999921647010217658
   PubMed Web of Science ®Google Scholar
• GoyJJStaufferJCSiegenthalerMA prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trialJ Am Coll Cardiol2005453081115653032
   PubMed Web of Science ®Google Scholar
• GregoryCRHuangXPrattREtreatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacementTransplantation199559655617533955
   PubMed Web of Science ®Google Scholar
• GrothCGBachmanLMoralesJMSirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study GroupTransplantation19996710364210221490
   PubMed Web of Science ®Google Scholar
• GruntzigARSenningASiegenthalerWENonoperative dilatation of coronary-artery stenosis: percutaneous transradial coronary angioplastyN Engl J Med1979301618449946
   PubMed Web of Science ®Google Scholar
• HoffmannRGuagliumiGMusumeciGVascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the Multicenter, randomized E-SIRIUS, and SIRIUS trialsCatheter Cardiovasc Interv20056649950616273564
   PubMedGoogle Scholar
• HolmesDRJrTeirsteinPSatlerLSirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trialJAMA200629512647316531619
   PubMed Web of Science ®Google Scholar
• HongMKParkSJAmerican College of Cardiology Annual Scientific Sessions 20052005 Oral presentation
   Google Scholar
• IakovouISchmidtTBonizzoniEIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsJAMA200529321263015870416
   PubMed Web of Science ®Google Scholar
• JangJSHongMKLeeCWComparison between sirolimus- and paclitaxel-eluting stents for the treatment of chronic total occlusionJ Invasive Cardiol200618205816670446
   PubMedGoogle Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol20064819320216814667
   PubMed Web of Science ®Google Scholar
• KaiserCBrunner-La RoccaHPBuserPTBASKET InvestigatorsIncremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET)Lancet2005366921916154019
   PubMed Web of Science ®Google Scholar
• KastratiADibraAEberleSSirolimus-eluting stents vs paclitaxel-eluting stents vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis; a randomized controlled trialJAMA2005a2931657115644543
   PubMed Web of Science ®Google Scholar
• KastratiADibraAEberleSSirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trialsJAMA2005b2948192516106007
   PubMed Web of Science ®Google Scholar
• KastratiADibraAMehilliJPredictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stentsCirculation2006113229330016682614
   PubMed Web of Science ®Google Scholar
• KelbaekHThuesenLHelqvistSThe Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trialJ Am Coll Cardiol2006474495516412876
   PubMed Web of Science ®Google Scholar
• KereiakesDJWangHPopmaJJPeriprocedural and late consequences of overlapping cypher sirolimus-eluting stentsJ Am Coll Cardiol200648213116814644
   PubMed Web of Science ®Google Scholar
• LeeJHKimHSLeeSWProspective Randomized Trial of SES vs. PES for the Treatment of Acute ST-Elevation Myocardial Infarction2006 American College of Cardiology Annual Scientific Sessions 2006: Late Breaking Trial Presentation
   Google Scholar
• LotanCAlmagorYKuiperKSirolimus-Eluting Stent in Chronic Total Occlusion: The SICTO StudyJ Interv Cardiol2006193071216881976
   PubMedGoogle Scholar
• MarxSOJayarmanTGoLORapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cellsCirc Res19957641277532117
   PubMed Web of Science ®Google Scholar
• MauriLOravEJKuntzRFLate loss in lumen diameter and binary restenosis for drug-eluting stent comparisonCirculation200511134354215967844
   PubMed Web of Science ®Google Scholar
• MehilliJDibraAKastratiARandomized trial of paclitaxel-and sirolimus-eluting stents in small coronary vesselsEur Heart J200627260616401670
   PubMed Web of Science ®Google Scholar
• MeierBSousaEGuagliumiGSirolimus-eluting stents in small vesselsAm Heart J200615110192716644326
   PubMedGoogle Scholar
• MorenoRFernandezCHernandezRDrug-Eluting Stent Thrombosis: Results From a Pooled Analysis Including 10 Randomised StudiesJ Am Coll Cardiol200545954915766835
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEThe RAVEL study: a randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularizationN Engl J Med200234617738012050336
   PubMed Web of Science ®Google Scholar
• MoriceMCColomboAMeierBSirolimus- vs paclitaxeleluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trialJAMA200629589590416493102
   PubMed Web of Science ®Google Scholar
• MosesJWLeonMBPopmaJJSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med200334913152314523139
   PubMed Web of Science ®Google Scholar
• MunozJSAbizaidAMintzGSIntravascular ultrasound study of effects of overlapping sirolimus-eluting stentsAm J Cardiol200493470314969627
   PubMedGoogle Scholar
• OrtolaniPArdissinoDCavalliniCEffect of sirolimus-eluting stents in diabetic patients with small coronary arteries (A SES-SMART sub-study)Am J Cardiol2005961393816275185
   PubMedGoogle Scholar
• ParkD-WParkS-WParkK-HFrequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-upAm J Cardiol200698352616860022
   PubMed Web of Science ®Google Scholar
• PanMSuarez de LezoJMedinaADrug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stentsAm Heart J20075315.e1717174630
   PubMedGoogle Scholar
• PhamSMShearsLLKawahardaNHigh local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosisTransplant Proc19983095349636385
   PubMed Web of Science ®Google Scholar
• PoonMMarxSOGalloRRapamycin inhibits vascular smooth muscle cell migrationJ Clin Invest199698277783
   Web of Science ®Google Scholar
• PostonRSBillinghamMHoytEGRapamycin reverses chronic graft vascular disease in a novel cardiac allograft modelCirculation1999100677410393683
   PubMed Web of Science ®Google Scholar
• SabateMJimenez-QuevedoPAngiolilloDJRandomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-elutin stent (DIABTETES) trialCirculation200511221758316203930
   PubMed Web of Science ®Google Scholar
• SchoferJSchluterMGershlickAHSirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS)Lancet20033621093914550694
   PubMed Web of Science ®Google Scholar
• SchampaertECohenEASchluterMThe Canadian Study of the Sirolimus-eluting Stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)J Am Coll Cardiol20044311101515028375
   PubMed Web of Science ®Google Scholar
• SchampaertEMosesJWSchoferJSirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thrombosesAm J Cardiol2006981364116784917
   PubMed Web of Science ®Google Scholar
• ScottNARestenosis following implantation of bare metal coronary stents: Pathophysiology and pathways involved in the vascular response to injuryAdv Drug Deliv Rev2006583587616733073
   PubMed Web of Science ®Google Scholar
• SehgalSNNakerHVezinaCRapamycin (AY-22, 989), a new antifungal antibiotic. II Fermentation, isolation and characterizationJ Antibiot (Tokyo)197528727321102509
   PubMed Web of Science ®Google Scholar
• SerruysPWde JaegerePKiemeneijiFA comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Stusy GroupN Engl J Med1994331489958041413
   PubMed Web of Science ®Google Scholar
• SerruysPWOngAMoriceMCArterial Revascularization Therapies Study Part II – Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesionsEuroInterv2005214756
   Google Scholar
• SinghKSunSVezinaCRapamycin (AY-22, 989), a new antifungal antibiotic. IV. Mechanism of actionJ Antibiot (Tokyo)19793262045
   Web of Science ®Google Scholar
• SousaJECostaMAAbizaidACLack of neointimal proliferation after implantation of sirolimus coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyCirculation2001103192511208675
   PubMed Web of Science ®Google Scholar
• SousaJECostaMAAbizaidALate four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimuseluting stentsCirculation20051112326915851603
   PubMed Web of Science ®Google Scholar
• SpierEHuangESModaliRInteraction of human cytomegalovirus with p53: possible role in coronary restenosisScand J Infact Dis Suppl1995997891
   PubMedGoogle Scholar
• StepkowskiSMChenHDalozePRapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the ratTransplanation199151226
   PubMed Web of Science ®Google Scholar
• Suarez De LezoJPanMCordoba and Las Palmas Drug-eluting Stent StudyJ Am Coll Cardiol200545Suppl A75A
   Google Scholar
• SpauldingCHenryPTeigerESirolimus-eluting versus uncoated stents in acute myocardial infarctionN Engl J Med2006355109310416971716
   PubMed Web of Science ®Google Scholar
• SuttorpMJLaarmanGJRahelBMPrimary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II)Circulation2006114921816908768
   PubMed Web of Science ®Google Scholar
• SuzukiTKopiaGHayashiSStent based delivery of sirolimus reduces neointimal formation in a porcine coronary modelCirculation200110411889311535578
   PubMed Web of Science ®Google Scholar
• UrbanPGershlickAHGuagliumiGSafety of coronary sirolimus-eluting stents in daily practice: one-year follow-up of the e-CYPHER registryCirculation200611314344116534015
   PubMed Web of Science ®Google Scholar
• Van HoutBAvan der WoudeTde JaegerePPCost-effectiveness of stent implantation versus PTCA: the BENESTENT experienceSemin Interv Cardiol1996126389552520
   PubMedGoogle Scholar
• VezinaCKudelskiASehgalSNRapamycin (AY-22, 989), a new antifungal antibiotic. I. Taxonomy pf the producing streptomycete and isolation of the active principleJ Antibiot (Tokyo)19752872161102508
   PubMed Web of Science ®Google Scholar
• WeiszGLeonMBHolmesDrJrTwo-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trialJ Am Coll Cardiol2006471350516580520
   PubMed Web of Science ®Google Scholar
• WindeckerSRemondinoAEberliFRSirolimus-eluting and paclitaxel-eluting stents for coronary revascularizationN Engl J Med20053536536216105989
   PubMed Web of Science ®Google Scholar